A 13-Year-Old Female with Xp11.2 Translocation Renal Cell
Carcinoma; The First Case Diagnosed at Siriraj Hospital
Suchanan Hanamornroongruang MD*, Jitsupa Treetipsatit MD*,
Bunchoo Pongtanakul MD**, Napakorn Seangchai MD*
Affiliation :
* Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
** Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Xp11.2 translocation renal cell carcinomas are rare tumors characterized by translocations involving chromosome
Xp11.2. These tumors are predominantly reported in pediatric patients.
The authors report Xp11.2 translocation renal cell carcinoma in a 13-year-old girl who presented with asymptomatic
palpable right renal mass. Right radical nephrectomy was performed and revealed a well-defi ned solid mass at the lower
pole of the kidney. Microscopically, the tumor was composed of sheets and nests of clear to pale eosinophilic cells with
some alveolar growth pattern. Psammoma bodies were detected. Immunohistochemically, the tumor cells marked with TFE3,
focally marked with smooth muscle actin, HMB-45, CD68, progesterone receptor (PR) and CD10 but did not mark with
epithelial markers (AE1/AE3, EMA and CAM5.2), vimentin, S-100 and p53.
The presence of psammoma bodies is an important diagnostic clue for these tumors. Cytogenetic study and/or
immunohistochemistry for TFE3 protein are needed for confi rming the diagnosis. Currently, surgery seems to be the most
effective therapy. Pediatric patients with these tumors are believed to have a favorable prognosis.
Keywords : Translocation renal cell carcinoma, Renal cell carcinoma, Pediatric renal carcinoma, Xp11.2 translocation,
TFE3
All Articles
Download